A large clinical trial has demonstrated a new screening for prostate cancer that's more accurate than the tests currently available. In research conducted by Northwestern Medicine, the new PSA test reduced the number of false positives and pinpointed prostate cancer more precisely, particularly the aggressive form of the disease.

Certain prostate tumors have the potential to become metastatic if not treated aggressively, according to new research from Dana-Farber Cancer Institute.

A new RNA therapy has been shown to prevent prostate-cancer stem cells from replicating, thanks to new research from University of Texas MD Anderson Cancer Center.

The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.

Interstitial brachytherapy may or may not hold advantages compared to other therapy options in men with localized prostate cancer, according to a new study.

The cancer drug cisplatin can be more effectively administered once encapsulated in a nanoparticle that targets prostate tumor cells and activates upon arrival.

Physical activity may play a vital role in longevity in men with prostate cancer, according to a new study from Harvard School of Public Health and the University of California, San Francisco.